Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

Eleni Tholouli, Effie Liakopoulou, Hayley M Greenfield, Bronwen E Shaw, Sudhir Tauro, Jennifer L Byrne, Mike Dennis, John Burthem, Guy S Lucas, Charles Craddock, Nigel H Russell, John A Liu Yin

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)318-20
Number of pages3
JournalBritish Journal of Haematology
Volume142
Issue number2
DOIs
Publication statusPublished - 2008

Cite this